Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension and obesity.

Ashish Aneja1, Fadi El-Atat, Samy I McFarlane

  • 1Department of Internal Medicine, State University of New York Downstate Medical Center, Brooklyn, New York 11203, USA.

Recent Progress in Hormone Research
|January 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling of Secretory mRNAs in Dengue Virus Infection: Possible Implications in Thrombocytopenia.

Journal of medical virology·2026
Same author

HuR enhances SARS-CoV-2 non-structural protein translation through the genomic 5'-UTR, by promoting polypyrimidine tract-binding protein binding.

Journal of virology·2026
Same author

Transcatheter aortic valve replacement at metropolitan teaching hospitals among patients with heart failure.

Current problems in cardiology·2026
Same author

Coronary Artery Calcium as a Key Indicator of Chemotherapy Cardiotoxicity in Patients With Colorectal Cancer.

American journal of therapeutics·2025
Same author

Enhanced ECCD36 signaling promotes skeletal muscle insulin resistance in female mice.

American journal of physiology. Endocrinology and metabolism·2024
Same author

PSPC1 Binds to HCV IRES and Prevents Ribosomal Protein S5 Binding, Inhibiting Viral RNA Translation.

Viruses·2024

Obesity is a significant risk factor for hypertension, with adipose tissue secreting factors like leptin that impact blood pressure. Weight loss through diet, exercise, or medication is key to managing this obesity-hypertension syndrome.

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiovascular Medicine

Background:

  • Obesity is prevalent in Western countries and strongly linked to hypertension.
  • Adipocytes secrete factors influencing blood pressure, challenging the view of fat as merely storage.
  • Leptin, secreted by adipocytes, may cause hypertension via sympathetic nervous system activation and kidney effects.

Purpose of the Study:

  • To explore the multifaceted relationship between obesity and hypertension.
  • To investigate the role of adipocyte-secreted factors, such as leptin, in hypertension development.
  • To discuss the impact of body fat distribution and potential management strategies.

Main Methods:

  • Review of current scientific literature on obesity and hypertension.

Related Experiment Videos

  • Analysis of the physiological mechanisms linking adipose tissue to blood pressure regulation.
  • Examination of the role of specific adipokines, like leptin, and the renin-angiotensin system.

    • Main Results:

    • Obesity contributes to hypertension through hormonal factors (leptin) and direct effects on the kidneys, including sodium reabsorption.
    • Central obesity is particularly associated with the obesity-hypertension syndrome.
    • Adipose tissue may possess a local renin-angiotensin system contributing to hypertension.

    Conclusions:

    • Weight loss is the primary management strategy for the obesity-hypertension syndrome.
    • Diet, exercise, and medications are crucial for achieving weight loss and lowering blood pressure.
    • Emerging anti-obesity medications and antihypertensives are vital components of a comprehensive treatment approach.